Serina Therapeutics Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3,531.0% | 3.9% | -31,540.0% | -15,703.9% | -21,157.1% | – | – | -2,884.6% | – | – | – | – | – | |
| 186.2% | 0.2% | 500.0% | 111.8% | 400.0% | – | – | 12.3% | – | – | – | – | – | |
| 0.0% | 1.7% | 1,060.0% | 898.0% | 7,828.6% | – | – | 684.6% | – | – | – | – | – | |
| -179.3% | -8.1% | 10,700.0% | -9,382.4% | 7,900.0% | – | – | 543.1% | – | – | – | – | – | |
| 410.3% | 2.3% | 280.0% | 0.0% | 21.4% | – | – | 35.4% | – | – | – | – | – | |
| -410.3% | -2.3% | -280.0% | – | -21.4% | – | – | -35.4% | – | – | – | – | – | |
| – | – | – | – | 36,271.4% | – | – | 8,066.9% | – | – | – | – | – | |
| – | – | – | – | 0.0% | – | – | 0.0% | – | – | – | – | – | |
| 6.9% | -0.4% | 54,560.0% | 10,523.5% | 614.3% | – | – | 4,284.6% | – | – | – | – | – | |
| 469.0% | 233.9% | 22,740.0% | -5,180.4% | -20,564.3% | – | – | 1,364.6% | – | – | – | – | – | |
| -3,941.4% | 1.7% | -31,820.0% | -15,703.9% | -21,178.6% | – | – | -2,884.6% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.